Beam Therapeutics Inc. (BEAM) Total liabilities 2019–2025
Beam Therapeutics Inc. (BEAM) total liabilities at each fiscal year-end, per SEC filings.
$242.8MFY2025 · since FY2019: $55.2M → $242.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $242.8M | -34.4% |
| FY2024 | $370.3M | -22.6% |
| FY2023 | $478.4M | -21.3% |
| FY2022 | $608.2M | -6.1% |
| FY2021 | $647.7M | +214.2% |
| FY2020 | $206.1M | +273.7% |
| FY2019 | $55.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More BEAM financial trends
BEAM RevenueBEAM Net incomeBEAM Net marginBEAM Gross profitBEAM Gross marginBEAM Operating incomeBEAM Operating marginBEAM Operating cash flowBEAM Free cash flowBEAM Capital expendituresBEAM Return on equityBEAM Stock buybacksBEAM Dividends paidBEAM Total assetsBEAM Shareholders’ equityBEAM overview →